Shuofeng Yuan

Discovery of SARS-CoV-2 Antivirals through Large-scale Drug Repositioning

Eytan Ruppin, Andrew I Su, Ren Sun, 2020, Nature.

Structure‐based discovery of clinically approved drugs as Zika virus NS2B‐NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo

Zheng Zhu, Horacio Pérez‐Sánchez, C. Yip, 2017, Antiviral research.

SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target

Dong Yang, Lei Wen, Cun Li, 2019, Nature Communications.

A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals

Peter G. Schultz, Ren Sun, Sebastian Burgstaller-Muehlbacher, 2020, bioRxiv.

Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19

Dong Yang, Yuxin Hou, Yue Chai, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Long SARS-CoV-2 nucleocapsid sequences in blood monocytes collected soon after hospital admission

Kwok-Hung Chan, Kaiming Tang, K. To, 2020, bioRxiv.